Zhu et al. (2020) showed a contribution of ASIC1a to increased ERK phosphorylation in the mechanism of liver fibrosis, as Pctx-1 treatment decreased the approximate 2-fold increase (without treatment) to a 1.5-fold increase. This evidence concerns the gene MAPK1 and Hepatic fibrosis.